For research use only. Not for therapeutic Use.
Desacetyl bisacodyl (DAB) is an active metabolite of two stimulant laxatives, bisacodyl and sodium picosulfate. DAB evokes several effects at the colon or rectum, including increased mucus and chloride secretion. Oral administration of bisacodyl leads to decreased expression of aquaporin-3 in the colon of rats. The effects of both DAB and bisacodyl can be blocked with cyclooxygenase (COX) inhibitors, suggesting that products of the COX signaling pathway contribute to laxative effects.
| Catalog Number | R009626 |
| CAS Number | 603-41-8 |
| Synonyms | 4,4’-(2-Pyridinylmethylene)bisphenol; 4,4’-Dihydroxydiphenyl(2-pyridyl)methane; Bis(4-hydroxyphenyl)(2-pyridyl)methane; DDPM; DDPM (pharmaceutical); Deacetylbisacodyl; La 96; USP Bisacodyl Related Compound A |
| Molecular Formula | C18H15NO2 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | 4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol |
| InChI | InChI=1S/C18H15NO2/c20-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(21)11-7-14/h1-12,18,20-21H |
| InChIKey | LJROKJGQSPMTKB-UHFFFAOYSA-N |
| SMILES | C1=CC=NC(=C1)C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O |
